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RESEARCH NOTE
Summary. High-level aminoglycoside resistance was assessed in 190 commensal erythromycin-resistant α-hemolytic
streptococcal strains. Of these, seven were also aminoglycoside-resistant: one Streptococcus mitis strain was resistant to high
levels of kanamycin and carried the aph(3´)-III gene, four S. mitis strains were resistant to high levels of streptomycin and
lacked aminoglycoside-modifying enzymes, and two S. oralis strains that were resistant to high levels of kanamycin and
streptomycin harbored both the aph(3´)-III and the ant(6) genes. The two S. oralis strains also carried the ant(6)-sat4-
aph(3´´)-III aminoglycoside-streptothricin resistance gene cluster, but it was not contained in a Tn5405-like structure. The
presence of this resistance gene cluster in commensal streptococci suggests an exchange of resistance genes between these
bacteria and enterococci or staphylococci. [Int Microbiol 2007; 10(1):57-60]
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Introduction
Viridans group streptococci (VGS) are important pathogens
in endocarditis, which most often arises from hematogenous
seeding from the oral cavity. Aminoglycosides are essential
chemotherapeutic agents. Although the resistance of VGS to
high levels of aminoglycosides is not common, resistance has
been reported in some clinical strains [7]. The molecular
basis of this resistance has been widely studied in gram-pos-
itive bacteria, but there is little information about the resist-
ance of VGS and especially of commensal isolates, which are
thought to act as reservoirs of resistance genes [2]. Amino-
glycoside resistance in gram-positive cocci is generally due
to the synthesis of aminoglycoside-modifying enzymes
(AMEs). Three AMEs are of particular significance among
enterococci and staphylococci, since they modify and thus
inactivate traditional aminoglycosides of therapeutic impor-
tance: (i) AAC(6´)/APH(2´´), encoded by aac(6´)/aph(2´´),
which inactivates gentamicin, kanamycin, tobramycin,
neomycin, and amikacin; (ii) ANT(4´)-I, encoded by ant(4´)-
Ia, which inactivates kanamycin, neomycin, tobramycin, and
amikacin; and (iii) APH(3´)-III, encoded by aph(3´)-IIIa,
which inactivates kanamycin and neomycin. These genes
may be located on a plasmid or in the chromosome, and are
often carried on transposable elements [5,12,14,15].
Streptomycin resistance by enzymatic modification is associ-
ated with the ant(6)-Ia gene, which encodes an ANT(6)-I
enzyme [15]; with the aph(3´´) gene, which encodes an
INTERNATIONAL MICROBIOLOGY (2007) 10:57–60
DOI: 10.2436/20.1501.01.8  ISSN: 1139-6709 www.im.microbios.org 
*Corresponding author: R. Gómez-Lus
Department of Microbiology, Zaragoza University School of Medicine
Domingo Miral, s/n 
50009 Zaragoza, Spain
Tel. +34-976761692. Fax +34-976761693
E-mail: gomezlus@unizar.es
Paula Cerdá,1 Pilar Goñi,1 Leticia Millán,1 Carmen Rubio,1,2 Rafael Gómez-Lus1*
1Department of Microbiology, Preventive Medicine and Public Health, Zaragoza University School of Medicine, Spain.
2Microbiology Service, Lozano Blesa University Clinic Hospital, Zaragoza, Spain
Received 2 October 2006 · Accepted 26 January 2007
Detection of the aminoglycoside-
streptothricin resistance gene cluster
ant(6)-sat4-aph(3´)-III in commensal
viridans group streptococci
58 INT. MICROBIOL. Vol. 10, 2007
APH(3´´) enzyme; and with the ant(3´´) (9) gene, which con-
fers streptomycin and spectinomycin resistance by encoding
an ANT(3´´) (9) enzyme [6]. Ribosomal mutations have also
been found for streptomycin resistance [14]. Furthermore,
bacteria carrying these resistance genes may also have an
ant(6)-sat4-aph(3´)-III gene cluster, conferring resistance to
aminoglycosides and streptothricin. In some strains, this
cluster is linked to the erm(B) gene [9,18]. In addition, it is
part of a transposon structure, Tn5405, found on the chromo-
some of staphylococci [18].
The aim of the present work was to assess the frequency
and molecular basis of high-level aminoglycoside resistance
in α-hemolytic streptococci from normal microbiota with
different macrolide resistance phenotypes, thereby contribut-
ing to our knowledge of the potential role of these bacteria as
reservoirs of resistance genes.
Materials and methods
Bacterial strains. The sample consisted of 190 erythromycin-resistant
α-hemolytic streptococci (189 VGS and 1 Streptococcus acidominimus) that
were previously studied for macrolide resistance phenotypes and genes. The
bacteria were mainly isolated from nasopharyngeal samples in the
Microbiology Service of the Lozano Blesa University Clinic Hospital,
(Zaragoza, Spain) [4]. Streptococci carrying either constitutive or inducible
resistance to macrolides, lincosamides, and streptogramin B (cMLSB,
iMLSB) phenotypes had the erm(B) gene, either alone or in combination with
the mef(A/E) gene (52.6%). Strains were identified on the basis of colony
morphology, α-hemolysis, optochin, susceptibility and Gram stain. Species
were identified using the API20 Strep System (API System, bioMerieux,
Marcy-l’Etoile, France). The isolates were assigned to a group/species
according to the criteria of Facklam [10].
Antimicrobial susceptibility testing. Antimicrobial susceptibili-
ty was tested using a standard agar diffusion test with commercially avail-
able disks (Bio-Rad, La Coquette, France). Minimum inhibitory concentra-
tions (MICs) were determined by a standard agar dilution method according
to the guidelines established by the Clinical and Laboratory Standards
Institute (CLSI) [8]. Steptococcus pneumoniae ATCC 49619 was used as a
control strain. The antibiotics tested included the aminoglycosides
kanamycin (Amersham Life Science, China), gentamicin, streptomycin, and
spectinomycin (Sigma, USA), and streptothricin (obtained from Dr. Jens
Jacob, Robert Koch Institut, Berlin, Germany). The disks contained 500 μg
of antibiotic, except for kanamycin (1000 μg). In the evaluation of MICs,
resistance to streptothricin was set at ≥1024 μg/ml, according to the method
of Werner et al. [18]. The resistance ranges for the other antibiotics were
those recommended by the CLSI [8].
Genetic analysis of resistance genes. Total DNA was isolated as
described by Ausubel et al. [1]. Plasmid DNA was prepared using a modifi-
cation of the alkaline lysis procedure [13]. Resistance genotypes were deter-
mined by PCR amplification of total DNA obtained from the high-level
aminoglycoside-resistant isolates. Oligonucleotide primers specific to the
genes aph(3´)-III, ant(6), ant(4´), ant(3´´)(9), aph(3´´), and sat4 were used
[3,6,7,14,15,17]. Strains harboring each of the antibiotic resistance genes
were included as positive controls and were obtained from our collection.
The presence of the ant(6)-sat4-aph(3´)-III gene cluster was investigated
with three additional PCRs using the following primer pairs: agc1 (5´-TA
TATATCCGAGGATTTGTG-3´, ant(6) gene)/agc2 (5´-CTTTTCAGG
GCTTTGTTCAT-3´, aph(3´)-III gene); Ps1/ant(6)R [16,18]; and
ant(6)F/aph(3´)-IIIR [16,17]. The PCR conditions were 35 cycles at 95ºC (1
min), 58ºC (Ps1/ant(6)R and ant(6)F/aph(3´)-IIIR) or 51ºC (agc1/agc2), and
72ºC (2 min). All reactions were done in 2.5 mM MgCl2, with 0.25 mM
deoxynucleoside triphosphates, 0.5 μM of each primer, and 2.5 U Taq DNA
polymerase. 
The presence of the transposon Tn5405 was studied by PCR as
described by Derbise et al. [9]. A direct linkage between the erm(B) and
ant(6) genes was screened according to the procedure of Werner et al. [18].
Amplifications were done in a thermal cycler (Perkin-Elmer Cetus,
Norwalk, CT, USA). The PCR products were resolved by electrophoresis on
1.5% agarose gels. Taq DNA polymerase (Promega, Madison, WI, USA)
was used to amplify fragments <2 kb, and LA Taq polymerase (TaKaRa,
Shiga, Japan) to amplify fragments >2 kb. The PCR products were purified
using GFX PCR DNA and the Gel Band Purification Kit and sequenced
using the DYEnamic ET Dye Terminator Cycle Sequencing Kit for
MegaBACE DNA Analysis Systems (Amersham Biosciences, Freiburg,
Germany).The Basic Local Alignment Search Tool (BLAST) software was
used to conduct identity searches of the GenBank database, available at the
website of the National Center for Biotechnology Information [http://www.
ncbi.nlm.nih.gov].
Results and Discussion
Aminoglycoside antibiotics are essential for the treatment of
infective endocarditis. Bacterial resistance to this group of
antibiotics appears to be associated with resistance to other
antibiotics, such as macrolide antibiotics. Genes encoding
AMEs, which confer aminoglycoside resistance, provide
excellent markers to detect the transfer of resistance genes
and to identify bacteria serving as resistance reservoirs.
Of the 190 strains of commensal erythromycin-resistant
α-hemolytic streptococci tested for high-level aminoglyco-
side resistance, seven (3.68%) were aminoglycoside-resistant.
Three strains (1.6%) were resistant to high levels of kanamycin
and five strains (3.2%) were resistant to high levels of strepto-
mycin (Table 1). One strain of S. mitis showed high-level
resistance to kanamycin and carried the aph(3´)-III gene. Four
(2.1%) S. mitis strains showed high-level resistance to strep-
tomycin but no AMEs were detected. Two S. oralis strains
(57 and 58b) showed high-level resistance to kanamycin and
streptomycin, and harbored both the aph(3´)-III and the
ant(6) genes. The ant(4´) gene was not found in kanamycin-
resistant isolates. Resistance to gentamicin or spectinomycin
was not exhibited by any of the strains, consistent with fail-
ure to detect the ant(3´´)(9) gene in the sample. Streptomycin
resistance in the four strains lacking AMEs might have been
due to ribosomal mutations, usually associated with MICs
>32,000 μg/ml or to other, as-yet-unidentified resistance
mechanisms [16].
Table 1 shows the association between aminoglycoside,
streptothricin and macrolide resistance patterns in VGS and
lists the corresponding genes. Other authors have also reported
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the presence of high-level aminoglycoside resistance in this
group of bacteria as well as an association with macrolides,
lincosamides, and streptogramin B (MLS) resistance markers
[7]. The two S. oralis isolates, 57 and 58b, were tested for
resistance to streptothricin (Table 1) and the presence of the
sat4 gene was demonstrated. 
Three additional PCRs were carried out to investigate the
presence of the ant(6)-sat4-aph(3´)-III gene cluster in these
two strains. The nucleotide sequences of the gene clusters of
S. oralis strains 57 and 58b were identical and showed 100%
identity with the sequences of ORF44 (ant(6)), ORF45
(sat4), and ORF46 (aph(3´)-III) of Enterococcus faecalis
plasmid pRE25 DNA (GenBank accession no. X92945), and
with the same cluster from different canine S. intermedius
isolates (GenBank accession no. AF299292), and 99% iden-
tity with the aminoglycoside-streptothricin resistance gene
cluster described in two strains of E. faecium (GenBank
accession no. AF330699). The S. oralis sequence showed a
point mutation at nucleotide 2136, which results in replace-
ment of the amino acid Ile by Val at position 225 in the puta-
tive E. faecium APH(3´)-III protein; however, this substitu-
tion does not seem to influence the kanamycin resistance
level. As far as we know, this is the first description of the
ant(6)-sat4-aph(3´)-III gene cluster in VGS.
In Staphylococcus sp., the ant(6)-sat4-aph(3´)-III gene
cluster has been described as a part of a Tn5405-like struc-
ture [9]. To determine whether the S. oralis cluster was also
part of a Tn5405-like structure in the two S. oralis strains,
PCR assays were done. PCR amplifications of the left end of
the element and from the aph(3´)-III gene to the ORFz were
negative; however, a 6-kb fragment was obtained for the
right end of the transposon. Seven hundred bp of the 5´ end
of the amplicon and 900 bp of the 3´ end were sequenced.
The former showed 62% amino-acid identity to the corre-
sponding fragment of lambda S2 prophage site-specific
recombinase (GenBank accession no. NP_688849.1), and the
latter displayed 51% amino-acid identity to the correspon-
ding fragment of the portal protein of bIL285 bacteriophage
(GenBank accession no. NP_4719081). These results sug-
gested that the ant(6)-sat4-aph(3´)-III gene cluster in the S.
oralis strains was inserted in a prophage. This possibility is
currently being further investigated in our laboratory.
Although the aminoglycoside-streptothricin resistance gene
cluster is generally part of the transposon Tn5405, a high
level of heterogeneity of Tn5405-related elements, with dif-
ferent arrangements including deletions and insertions of
ORFs, has been described in enterococci and staphylococci
[9,18]. Nonetheless, the ant(6)-sat4-aph(3´)-III gene cluster
is a conserved region, as was the case in the S. oralis strains.
Linkage between erm(B) and this gene cluster was
recently described in E. faecium and Staphylococcus inter-
medius [18]. The S. oralis isolates used in the present study
also had the erm(B) gene, but PCR analysis revealed no asso-
ciation between this gene and the aminoglycoside-strep-
tothricin resistance gene cluster. The alkaline lysis technique
did not provide evidence for the presence of plasmids in our
isolates, which suggests either that high-level resistance to
kanamycin, streptomycin, and streptothricin is chromosoma-
lly mediated, as reported by other authors for VGS, or that
the cluster is located on a large plasmid [7]. High-level resist-
AMINOGLYCOSIDE-STREPTOTHRICIN RESISTANCE
Table 1. Aminoglycoside, streptothricin, and macrolide resistance patterns and genes in commensal viridans group
streptococci.
Aminoglycoside resistance Macrolide resistance
Strain Resistance pattern MIC (μg/ml) Genotype Phenotype Genotype
Streptococcus oralis 57 Sm Km St Sm: 4096 ant(6) cMLSB erm(B), mef(E)
Km: 8192 aph(3´)-III
St : >2048 sat4
S. oralis 58b Sm Km St Sm: 4096 ant(6) cMLSB erm(B), mef(E)
Km: 8192 aph(3´)-III
St: >2048 sat4
S. mitis 128 Sm >32,000 – iMLSB erm(B)
S. mitis 138 Sm 16,000 – iMLSB erm(B), mef(E)
S. mitis 191 Sm >32,000 – cMLSB erm(B)
S. mitis 223 Km >8192 aph(3´)-III iMLSB erm(B), mef(E)
S. mitis 257 Sm 32,000 – cMLSB erm(B)
Km, kanamycin; Sm, streptomycin; St, streptothricin. 
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ance to aminoglycosides in VGS is of concern. In fact, this
group of bacteria might act as a reservoir of other antibiotic
resistances, perhaps including aminoglycosides [2]. 
Many studies have been conducted to demonstrate the
potential role of commensal flora as reservoirs of resistance
genes [4], and the exchange of these genes between strains of
human and animal origin [11]. For these purposes, the study
of aminoglycoside-resistance genes has been especially use-
ful. Our results demonstrated the presence in commensal S.
oralis of an aminoglycoside-streptothricin resistance gene
cluster found in staphylococci and enterococci, which sug-
gests an exchange of resistance genes between these bacteria.
This type of exchange might also occur with other pathogen-
ic bacteria sharing a habitat with S. pneumoniae. The pres-
ence in commensal S. oralis of the sat4 gene, which confers
resistance to streptothricin, an antibiotic never used in
humans or for ergotropic purposes in Spain, leads us to think
that there is probably a co-selection of this gene via the
antibiotic resistances encoded by the aph(3´)-III and/or the
ant(6) genes. 
The results confirm the need to continue surveillance of
the resistance genes harbored by commensal bacteria. The
DNA sequence of the ant(6)-sat4-aph(3´)-III gene cluster of
S. oralis 58b has been assigned GenBank accession no.
AY712687.
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